Autoimmune optic neuropathy
A rare optic neuropathy with autoimmune serology and poor visual prognosis.
Autoimmune optic neuropathy (AON) is a clinical syndrome characterized by chronically progressive or recurrent vision loss associated with serological evidence of autoimmunity, particularly positive antinuclear antibody (ANA) despite not meeting criteria for systemic lupus erythematosus (SLE). It was first described in 1982 and is considered a possible forme fruste of SLE-associated optic neuropathy.
Quick Facts
- First described
- 1982
- Associated condition
- Systemic lupus erythematosus (SLE)
- Key feature
- Steroid-responsive and steroid-dependent vision loss
- Prevalence in sle
- 1-2% of SLE patients develop optic neuropathy
Facts from the source article.
Background
Autoimmune optic neuropathy (AON) was first described in 1982. It presents with visual loss and signs of optic nerve dysfunction, such as loss of color vision, afferent pupil defect, and sometimes abnormalities of the optic disc. The clinical features can be variable and include acute anterior or retrobulbar optic neuritis sometimes associated with pain, anterior or retrobulbar ischemic optic neuropathy not associated with pain, and chronic progressive vision loss that mimics a compressive lesion. The main features that differentiate AON from typical demyelinating optic neuritis are poor recovery of vision and a chronic, recurrent, or bilateral course. Workup for multiple sclerosis, including MRI, will be negative.
More in Steroid-responsive Inflammatory Conditions
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced
